BATS BZX Real-Time Price
As of 2:32pm ET
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +93.55% increase from the last price of 3.10.
The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.